Dixon Hubard Feinour & Brown Inc Precigen, Inc. Transaction History
Dixon Hubard Feinour & Brown Inc
- $842 Million
- Q2 2022
A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 85,873 shares of PGEN stock, worth $133,103. This represents 0.01% of its overall portfolio holdings.
Number of Shares
85,873
Previous 87,573
1.94%
Holding current value
$133,103
Previous $185,000
37.84%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding PGEN
# of Institutions
142Shares Held
145MCall Options Held
208KPut Options Held
43.7K-
Third Security, LLC83.5MShares$129 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.5MShares$27.1 Million1.27% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$16.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.77MShares$10.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.03MShares$4.7 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $323M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...